Circulating microRNA-122a as a diagnostic marker for hepatocellular carcinoma

References

• CuradoMPEdwardsBShinHRCancer Incidence in Five ContinentsLyon, FranceInternational Agency for Research in Cancer Scientific Publications2007 Available from: http://www.iarc.fr/en/publications/pdfs-online/epi/sp160/CI5vol9-A.pdfAccessed April 28, 2013
   Google Scholar
• SchwartzMRoayaieSKonstadoulakisMStrategies for the management of hepatocellular carcinomaNat Clin Pract Oncol2007442443217597707
   PubMedGoogle Scholar
• CalinGACroceMCMicroRNA signatures in human cancersNat Rev Cancer2006685786617060945
   PubMed Web of Science ®Google Scholar
• LuJGetzGMiskaEAMicroRNA expression profiles classify human cancersNature200543583483815944708
   PubMed Web of Science ®Google Scholar
• LadeiroYCouchyGBalabaudCMicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutationsHepatology2008471955196318433021
   PubMed Web of Science ®Google Scholar
• AmbrosVThe functions of animal microRNAsNature200443135035515372042
   PubMed Web of Science ®Google Scholar
• Esquela-KerscherASlackFJOncomirs – microRNAs with a role in cancerNat Rev Cancer2006625926916557279
   PubMed Web of Science ®Google Scholar
• FuXWangQChenJClinical significance of miRNA-221 and its inverse correlation with p27(Kip1) in hepatocellular carcinomaMol Biol Rep2011383029303520146005
   PubMed Web of Science ®Google Scholar
• GramantieriLFornariFFerracinMMicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocalityClin Cancer Res2009155073508119671867
   PubMed Web of Science ®Google Scholar
• GalardiSMercatelliNGiordaEmiRNA-221 and miRNA-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27 Kip1J Biol Chem2007282237162372417569667
   PubMed Web of Science ®Google Scholar
• FornariFGramantieriLFerracinMMiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinomaOncogene2008275651566118521080
   PubMed Web of Science ®Google Scholar
• TannapfelAGrundDKatalinicADecreased expression of p27 protein is associated with advanced tumor stage in hepatocellular carcinomaInt J Cancer20008935035510956409
   PubMed Web of Science ®Google Scholar
• NakaiSMasakiTShiratoriYExpression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survivalInt J Oncol20022076977511894123
   PubMed Web of Science ®Google Scholar
• KutayHBaiSDattaJDownregulation of miRNA-122 in the rodent and human hepatocellular carcinomasJ Cell Biochem20069967167816924677
   PubMed Web of Science ®Google Scholar
• ChangJNicolasEMarksDmiRNA-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1RNA Biol2004110611317179747
   PubMedGoogle Scholar
• FornariFGramantieriLGiovanniniCMiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cellsCancer Res2009695761576719584283
   PubMed Web of Science ®Google Scholar
• TsaiWCHsuPWLaiTCMicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinomaHepatology2008491571158219296470
   PubMed Web of Science ®Google Scholar
• BaiSNasserMWWangBMicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to SorafenibJ Biol Chem2009284320153202719726678
   PubMed Web of Science ®Google Scholar
• MitchellPSParkinRKKrohEMCirculating microRNAs as stable blood-based markers for cancer detectionProc Natl Acad Sci U S A2008105105131051818663219
   PubMed Web of Science ®Google Scholar
• American Cancer Society (ACS)Liver Cancer2012 http://www.cancer.org/acs/groups/cid/documents/webcontent/003114-pdf.pdfAccessed January 18, 2013
   Google Scholar
• GarzonRCalinGACroceCMMicroRNAs in cancerAnnu Rev Med20096016717919630570
   PubMed Web of Science ®Google Scholar
• ChenYTKitabayashiNZhouXKFaheyTJ3rdScognamiglioTMicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinomaMod Pathol2008211139114618587330
   PubMed Web of Science ®Google Scholar
• TaylorDDTaylorCGMicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancerGynecol Oncol2008110132118589210
   PubMed Web of Science ®Google Scholar
• LiuRZhangCHuZA five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosisEur J Cancer20114778479121112772
   PubMed Web of Science ®Google Scholar
• IorioMVFerracinMLiuCGMicroRNA gene expression deregulation in human breast cancerCancer Res2005657065707016103053
   PubMed Web of Science ®Google Scholar
• YanaiharaNCaplenNBowmanEUnique micro-RNA molecular profiles in lung cancer diagnosis and prognosisCancer Cell2006918919816530703
   PubMed Web of Science ®Google Scholar
• RongMChenGDangYIncreased MiR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitroBMC Cancer2013132123320393
   PubMed Web of Science ®Google Scholar
• YangQERacicotKEKaucherAVOatleyMJOatleyJMMicroRNAs 221 and 222 regulate the undifferentiated state in mammalian male germ cellsDevelopment201314028029023221369
   PubMed Web of Science ®Google Scholar
• XuJWuCCheXCirculating microRNAs, miRNA-21, miRNA-122, and miRNA-223, in patients with hepatocellular carcinoma or chronic hepatitisMol Carcinog20115013614221229610
   PubMed Web of Science ®Google Scholar
• PortaCDe AmiciMQuagliniSCirculating interleukin-6 as a tumor marker for hepatocellular carcinomaAnn Oncol20081935335817962206
   PubMed Web of Science ®Google Scholar
• MaoYYangHXuHGolgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinomaGut2010591687169320876776
   PubMed Web of Science ®Google Scholar
• ShenQFanJYangXRSerum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre studyLancet Oncol20121381782622738799
   PubMed Web of Science ®Google Scholar
• GiannelliGMarinosciFTrerotoliPSCCA antigen combined with alpha-fetoprotein as serologic markers of HCCInt J Cancer200511750650915906357
   PubMed Web of Science ®Google Scholar
• GiannelliGFransveaETrerotoliPClinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patientsClin Chim Acta200738314715217582392
   PubMed Web of Science ®Google Scholar
• LanfordREHildebrandt-EriksenESPetriATherapeutic silencing of microRNA-122 in primates with chronic hepatitis c virus infectionScience201032719820119965718
   PubMed Web of Science ®Google Scholar
• KaplanDEReddyKRRising incidence of hepatocellular carcinoma: the role of hepatitis B and C; the impact on transplantation and outcomesClin Liver Dis2003768371414509534
   PubMedGoogle Scholar
• El-SeragHBHepatocellular carcinoma: an epidemiologic viewJ Clin Gastroenterol200235S72S7812394209
   PubMed Web of Science ®Google Scholar
• El-SeragHBDavilaJAPetersenNJMcGlynnKAThe continuing increase in the incidence of hepatocellular carcinoma in the United States: an updateAnn Intern Med2003139128
   Web of Science ®Google Scholar
• Di BisceglieAMLyraACSchwartzMReddyRKMartinPGoresGHepatitis C-related carcinoma in the United States: influence of ethnic statusAm J Gastroenterol2003982060206314499788
   PubMed Web of Science ®Google Scholar
• QiuLPFanHXJinWSMiR-122-induced downregulation of HO-1 negatively affects miRNA-122-mediated suppression of HBVBiochem Biophys Res Commun201039877177720633528
   PubMed Web of Science ®Google Scholar
• FanGWangCMTianCMiR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3Oncol Rep2011261281128621725618
   PubMed Web of Science ®Google Scholar